New in MMWR: Respiratory Syncytial Virus Vaccines, Arthritis Among Children, and more

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

This Week in MMWR: Vol. 72, July 21, 2023

July 21, 2023

WEEKLY REPORT

	Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 A single respiratory syncytial virus (RSV) vaccine dose demonstrated moderate to high efficacy in preventing symptomatic RSV-associated lower respiratory tract disease among adults aged 60 years and older.

• Soft Tick Relapsing Fever — United States, 2012–2021
• Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — World Health Organization African Region, 2016–2021
• Arthritis Among Children and Adolescents Aged <18 Years — United States, 2017–2021
• Notes from the Field: Autism Spectrum Disorder Among Children with Laboratory Evidence of Prenatal Zika Virus Exposure — Puerto Rico, 2023
• Notes from the Field: An Outbreak of Shiga Toxin–Producing Escherichia coli O157:H7 Associated with a Farming Camp — Tennessee, 2022

READ MORE

QUICKSTATS

Percentage of Children and Adolescents Aged ≤17 Years Who Have Experienced a Specified Stressful Life Event, by Type of Event and Family Income§ — National Health Interview Survey, United States, 2021

PDF of this Issue (link).

CONTINUING EDUCATION

READ MORE

PODCAST

MMWR Weekly Briefing Podcast: Week of July 3

The latest MMWR Weekly Briefing is live. Topics include: birth defect-associated hospitalizations in the United States, the introduction of new vaccines worldwide, and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |